Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 23:2021:5557582.
doi: 10.1155/2021/5557582. eCollection 2021.

C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients

Mahmoud Sadeghi-Haddad-Zavareh  1 , Masomeh Bayani  1 , Mehran Shokri  1 , Soheil Ebrahimpour  1 , Arefeh Babazadeh  1 , Rahele Mehraeen  2 , Emadoddin Moudi  3 , Ali Rostami  1 , Mohammad Barary  4 , Akram Hosseini  5 , Ali Bijani  2 , Mostafa Javanian  1
Affiliations

C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients

Mahmoud Sadeghi-Haddad-Zavareh et al. Interdiscip Perspect Infect Dis. .

Abstract

While some biomolecules have been explored to identify potential biomarkers for the prognosis of COVID-19 patients, there is no reliable prognostic indicator of the disease progression and severity. We aimed to evaluate the ability of the C-reactive protein (CRP) to predict COVID-19 infection outcome. This retrospective study was conducted on 429 patients diagnosed with COVID-19 between March 30, 2020, and April 30, 2020. The study population was divided into severe (n = 175) and nonsevere cases (n = 254). Data on demographic characteristics, clinical features, and laboratory findings on admission were collected. The proportion of patients with increased CRP levels was significantly higher in severe cases than in nonsevere patients. Analysis of the receiver operating characteristic (ROC) curve found that CRP could be used as an independent factor in predicting the severity of COVID-19. Also, patients with CRP >64.75 mg/L were more likely to have severe complications. In conclusion, CRP serum levels can predict the severity and progression of illness in patients with COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Receiver operating characteristic (ROC) curves of C-reactive protein for predicting the disease severity in COVID-19 patients.
See this image and copyright information in PMC

References

    1. Javanian M., Bayani M., Shokri M., et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Romanian Journal of Internal Medicine. 2020;58(3):161–167. doi: 10.2478/rjim-2020-0013. - DOI - PubMed
    1. Hsiang S., Allen D., Annan-Phan S., et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262–267. doi: 10.1038/s41586-020-2404-8. - DOI - PubMed
    1. Mas-Coma S., Jones M. K., Marty A. M. COVID-19 and globalization. One Health. 2020;9 doi: 10.1016/j.onehlt.2020.100132. - DOI - PMC - PubMed
    1. WHO. Coronavirus Disease ( COVID-19) Geneva, Switzerland: WHO; 2020. Situation Report.
    1. Ling W. C-reactive protein levels in the early stage of COVID-19. Médecine et Maladies Infectieuses. 2020;50:332–334. - PMC - PubMed

LinkOut - more resources